Febuxostat in the therapy of gout: from theory to practice
Gout is a chronic disease that requires permanent urate-lowering therapy. Allopurinol is the gold standard of this therapy. The novel drug febuxostat, a selective xanthine oxidase inhibitor, has been synthesized and introduced into clinical practice in the last 10 years. The paper reviews the litera...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Russo |
| Publicado: |
IMA-PRESS LLC
2018-01-01
|
| Colección: | Современная ревматология |
| Materias: | |
| Acceso en línea: | https://mrj.ima-press.net/mrj/article/view/800 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|